Trials / Unknown
UnknownNCT00181025
Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
Isolated Pelvic and Limb Perfusion With 1mg TNFa in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
This study looks at isolated pelvic perfusion and limbs' girdle with 1 mg tumor necrosis factor alpha (TNFa) in the treatment of locally advanced sarcoma of the pelvis and limbs' girdle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tasonermine (TNFa) | |
| DRUG | Melphalan |
Timeline
- Start date
- 2004-05-01
- First posted
- 2005-09-16
- Last updated
- 2007-06-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00181025. Inclusion in this directory is not an endorsement.